The status of serum vitamin D in patients with active Behcet's disease compared with controls

International Journal of Rheumatic Diseases

Volumn 17, Issue 4, 2014, Pages 430-434

  Khabbazi, Alireza ^a   Rashtchizadeh, Nadereh ^a   Ghorbanihaghjo, Amir ^b   Hajialiloo, Mehrzad ^a   Ghojazadeh, Mortasa ^a   Taei, Ramin ^a   Kolahi, Sousan ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

25(OH)D; Behcet's disease; Pathogenesis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BEHCET SYNDROME; BLOOD; CASE CONTROL STUDY; DOWN REGULATION; RISK FACTOR; YOUNG ADULT;

ADULT; BEHCET SYNDROME; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; MALE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84901279444     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12153     Document Type: Article

References (33)

1. Suzuki Kurokawa M, Suzuki N (2004) Behcet's disease. Clin Exp Med 4 (1), 10-20.
2. Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42, 1967-74.
3. Do JE, Kwon SY, Park S, Lee ES (2008) Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology (Oxford) 47, 840-8.
4. Hayes CE, Nashold FE, Spach KM, Pedersen LB (2003) The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-Grand) 49, 277-300.
5. Griffin MD, Xing N, Kumar R (2003) Vitamin D and its analogs as regulators of immune activation and antigen presentation. Ann Rev Nutr 23, 17-45.
6. Cantorna MT, Zhu Y, Froicu M, Wittke A (2004) Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80, 1717-20S.
7. Rigby WF, Waugh M, Graziano RF (1990) Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1, 25-dihydroxyvitamin D3. Blood 76 (1), 189-97.
8. Penna G, Adorini L (2000) 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164, 2405-11.
9. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA (2001) 1-alpha, 25-dihydroxyvitamin D3 (1, 25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145, 351-7.
10. Berer A, Stockl J, Majdic O et al. (2000) 1, 25-dihydroxyvitamin D (3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28, 575-83.
11. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R (2000) Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270, 701-8.
12. D'Ambrosio D, Cippitelli M, Cocciolo MG et al. (1998) Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101, 252-62.
13. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296, 2832-8.
14. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G (2006) Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29, 722-4.
15. Cutolo M, Otsa K, Laas K et al. (2006) Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24, 702-4.
16. Pappa HM, Grand RJ, Gordon CM (2006) Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 12, 1162-74.
17. Szodoray P, Nakken B, Gaal J et al. (2008) The complex role of vitamin D in autoimmune diseases. Scand J Immunol 68, 261-9.
18. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50, 72-7.
19. Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A (2010) Vitamin D modulates peripheral immunity in patients with Behçet's disease. Clin Exp Rheumatol 28(4, Suppl. 60), S50-7.
20. Nielen MM, van Schaardenburg D, Lems WF et al. (2006) Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al. Arthritis Rheum 54, 3719-20.
21. Garcia-Lozano JR, Gonzalez-Escribano MF, Valenzuela A, Garcia A, Nunez-Roldan A (2001) Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet 28, 89-93.
22. Oelzner P, Müller A, Deschner F et al. (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62 (3), 193-8.
23. Kröger H, Penttilä IM, Alhava EM (1993) Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 22 (4), 172-7.
24. Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL (2005) Association of 1, 25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporosis Int 16, 1999-2004.
25. Cutolo M, Otsa K, Laas K et al. (2006) Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24, 702-4.
26. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56, 2143-9.
27. Karatay S, Yildirim K, Karakuzu A et al. (2011) Vitamin D status in patients with Behcet's Disease. Clinics 66, 721-3.
28. International Team for the Revision of the International Criteria for Behcet's Disease (2006) Revision of the International Criteria for Behcet's Disease (ICBD). Clin Experi Rheumatol 24, S14-5.
29. Davatchi F, Schirmer M, Zouboulis C, Assad-Khalil S, Calamia KT on behalf International Team for the Revision of the International Criteria for Behcet's Disease (2007) Evaluation and Revision of the International Study Group Criteria for Behcet's Disease. Proceedings of the American College of Rheumatology Meeting, Boston, MA, USA, abstract 1233.
30. Davatchi F, Akbarian M, Shahram F, Tebbi M, Chams C, Chams H (1991) Iran Behcet's disease dynamic activity measure. Abstracts of the XIIth European congress of rheumatology. Hungarian Rheumatol 32, 134. (abstract FP10-100).
31. Bhakta B, Brennan P, James T, Chamberlain M, Noble B, Silman A (1999) Behcet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38, 728-33.
32. Shahram F, Khabbazi A, Nadji A, Ziaie N, Banihashemi AT, Davatchi F (2009) Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease. Mod Rheumatol 19, 536-41.
33. Zold E, Szodoray P, Gaal J et al. (2008) Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 10, R123.